Monitoring Huntington's Disease Mortality across a 30-Year Period: Geographic and Temporal Patterns

Neuroepidemiology

Volumn 47, Issue 3-4, 2017, Pages 155-163

  Sánchez Díaz, Germán ^a   Arias Merino, Greta ^a   Villaverde Hueso, Ana ^a,c   Morales Piga, Antonio ^a,c   Abaitua Borda, Ignacio ^a,c   Hens, Manuel ^a,c   Bermejo Sánchez, Eva ^a,b,c   Posada De La Paz, Manuel ^a,c   Alonso Ferreira, Verónica ^a,c  

^a Instituto de Salud Carlos III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Huntington's disease; Mortality; Population based; Spain; Spatial analysis

Indexed keywords

ADULT; AGE; ARTICLE; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MORTALITY RATE; MORTALITY RISK; SPAIN; STANDARDIZED MORTALITY RATIO; TREND STUDY; GEOGRAPHY; REGISTER; SEX DIFFERENCE; TIME FACTOR;

AGE FACTORS; FEMALE; GEOGRAPHY; HUMANS; HUNTINGTON DISEASE; MALE; REGISTRIES; SEX FACTORS; SPAIN; TIME FACTORS;

EID: 85001038041     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000452860     Document Type: Article

References (44)

1. Bates GP, Dorsey R, Gusella JF, et al: Huntington disease. Nat Rev Dis Primers 2015; 1: 15005.
2. Armstrong MJ, Miyasaki JM: Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 2012; 79: 597-603.
3. Walker FO: Huntington's disease. Semin Neurol 2007; 27: 143-150.
4. Gusella JF, Wexler NS, Conneally PM, et al: A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306: 234-238.
5. Falush D, Almqvist EW, Brinkmann RR, et al: Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am J Hum Genet 2001; 68: 373-385.
6. Bates GP: History of genetic disease: the molecular genetics of Huntington disease - a history. Nat Rev Genet 2005; 6: 766-773.
7. Benitez J, Fernández E, García Ruiz P, Robledo M, Ramos C, Yébenes J: Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's disease. Hum Genet 1994; 94: 563-564.
8. Losekoot M, Van Belzen MJ, Seneca S, Bauer P, Stenhouse SA, Barton DE; European Molecular Genetic Quality Network (EMQN): EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease. Eur J Hum Genet 2013; 21: 480-486.
9. Pringsheim T, Wiltshire K, Day L, et al: The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord 2012; 27: 1083-1091.
10. Nakashima K, Watanabe Y, Kusumi M, et al: Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan. Neuroepidemiology 1996; 15: 126-131.
11. Chen YY, Lai CH: Nationwide populationbased epidemiologic study of Huntington's disease in Taiwan. Neuroepidemiology 2010; 35: 250-254.
12. United Nations: Data Bases for Mortality Measurement. United Nations Publication, Sales No. E.83.XIII, 1984.
13. Joubert J, Rao C, Bradshaw D, et al: Characteristics, availability and uses of vital registration and other mortality data sources in postdemocracy South Africa. Glob Health Action 2012; 5: 1-19.
14. Ascuntar-Tello J, Jaimes F: Ronda clínica y epidemiológica: sistemas de información geográfica (SIG) en salud. Iatreia 2016; 29: 97-103.
15. European Union: European Commission: Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Rare Diseases: Europe's Challenges, 11 November 2008, COM (2008) 679 final. http://ec.europa.eu/health/ph-threats/non-com/docs/rare-com-en.pdf.
16. Ekestern E, Lebhart G: Long-term monitoring of the mortality trend of Huntington's disease in Austria. Eur J Epidemiol 2005; 20: 169-172.
17. Sipilä JO, Hietala M, Siitonen A, et al: Epidemiology of Huntington's disease in Finland. Parkinsonism Relat Disord 2015; 21: 46-49.
18. Ramalle-Gomara E, Gonzalez MA, Perucha M, et al: Mortalidad por la enfermedad de Huntington en España en el período 1981-2004. Rev Neurol 2007; 45: 88-90.
19. Calcedo Ordóñez A: [Huntington's disease in the Province of Cadiz. Epidemiological and familial study]. Rev Clin Esp 1970; 119: 333-344.
20. Ruiz JJ, Ortin A, Cacho J, et al: Corea de Huntington: estudio epidemiológico en la provincia de Salamanca. Arch Neurobiol 1985; 48: 302-303.
21. Burguera JA, Solís P, Salazar A: [Estimate of the prevalence of Huntington disease in the Valencia region using the capture-recapture method]. Rev Neurol 1997; 25: 1845-1847.
22. Vicente E, García-Amigot F, Gastón MI, et al: Prevalence on Huntington disease in Navarra (Spain). Sensitivity and positive predictive value of different sources of ascertainment. J Neurol Neurosurg Psychiatry 2014; 85(suppl 1):A77.
23. Velleman PF: Definition and comparison of robust nonlinear data smoothing algorithms. J Am Stat Assoc 1980; 75: 609-615.
24. Arias Lopez M: La comarca como entidad natural, histórica y administrativa. Dykinson, S.L., 2013.
25. Besag JE, York J, Molliè A: A Bayesian image restoration with two applications in spatial statistics. Ann Inst Statist Math 1991; 43: 1-59.
26. Lanska DJ, Lavine L, Lanska MJ, et al: Huntington's disease mortality in the United States. Neurology 1988; 38: 769-772.
27. Burguera Hernández JA, Láinez Andrés JM, Blasco Olcina R, et al: Mortalidad por enfermedad de Huntington en España, 1975-1979. Rev Neurol 1990; 18: 13-16.
28. Evans SJ, Douglas I, Rawlins MD, et al: Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry 2013; 84: 1156-1160.
29. Sipilä JO, Päivärinta M: Why we still need more research on the epidemiology of Huntington's disease. Neuroepidemiology 2016; 46: 154-155.
30. Rawlins MD, Wexler NS, Wexler AR, et al: The prevalence of Huntington's disease. Neuroepidemiology 2016; 46: 144-153.
31. Roos RA: Huntington's disease: a clinical review. Orphanet J Rare Dis 2010; 5: 40.
32. Young AB, Shoulson I, Penney JB, et al: Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 1986; 36: 244-249.
33. Paradisi I, Hernández A, Arias S: Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation. J Hum Genet 2008; 53: 127-135.
34. Pridmore SA: The large Huntington's disease family of Tasmania. Med J Aust 1990; 153: 593-595.
35. Rivera-Navarro J, Cubo E, Mariscal N: Analysis of the reasons for non-uptake of predictive testing for Huntington's disease in Spain: a qualitative study. J Genet Couns 2015; 24: 1011-1021.
36. Ramos-Arroyo MA, Moreno S, Valiente A: Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing. J Neurol Neurosurg Psychiatry 2005; 76: 337-342.
37. Yudkin JS, Ritcher B, Gale E: Uncovering the true prevalence of Huntington's disease. Lancet 2010; 376: 18-19.
38. Solis-Pérez MP, Burguera JA, Palu F, et al: Resultados de un programa de diagnóstico presintomático en la enfermedad de Huntington: evaluación de un periodo de 6 años. Rev Neurol 2001; 16: 348-352.
39. Farrer LA: Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet 1986; 24: 305-311.
40. Schoenfeld M, Myers RH, Cupples LA, et al: Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry 1984; 47: 1283-1287.
41. Dorey J, Trigo P, Garcia de Yébenes, Tourmi M: M07 burden of Huntington's disease in Spain. J Neurol Neurosurg Psychiatry 2012; 83(suppl 1):A48.
42. Hubers AA, Van Duijn E, Roos RA, et al: Suicidal ideation in a European Huntington's disease population. J Affect Disord 2013; 151: 248-258.
43. Bindler L, Travers D, Millet B; [Suicide in Huntington's disease: a review]. Rev Med Suisse 2009; 5: 646-648.
44. Fernández Hawrylak M, Grau C, Trigo P: [The impact of Huntington's disease on the family]. An Sist Sanit Navar 2012; 35: 295-307.